Promising drug combination for multiple myeloma treatment
RCSI research has found that venetoclax, a medication currently approved for leukaemia, has benefits for patients with multiple myeloma when used in combination with another drug. This discovery offers a new avenue of treatment options for the currently incurable disease. Multiple myeloma (MM) is a type of blood cancer that is newly diagnosed in around … Read more
